LOINC
Version 2.73

57549-817-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --2 days post dose dexamethasoneActive

Part Description

LP14974-7   17-Hydroxyprogesterone
17-hydroxyprogesterone (17-OHP) is a steroid that is a member of the adrenal biosynthetic pathway and measured in order to diagnose congenital adrenal hyperplasia (CAH). Classic CAH is suspected when virilisation is seen in females at birth. The diagnosis of CAH in boys can be delayed. CAH is characterized by decreased cortisol as a result of a mutation in the CYP21A2 gene, which encodes the enzyme 21-hydroxylase. Increased blood concentrations of 17-OHP indicate a deficiency in 21-hydroxylase since 17-OHP is the substrate for 21-hydroxylase. Reduced levels of 21-hydroxylase negatively affect the production of cortisol. CAH is among the most frequent genetic disorders in humans. The severity of the physical manifestations are related to the degree of 21-hydroxylase deficiency.[PMID:24711560] Source: Regenstrief LOINC

Fully-Specified Name

Component
17-Hydroxyprogesterone^2D post dose dexamethasone
Property
MCnc
Time
Pt
System
Ser/Plas
Scale
Qn
Method

Additional Names

Short Name
17OHP 2D p Dex SerPl-mCnc
Display Name
17-Hydroxyprogesterone 2 days post dose dexamethasone [Mass/Vol]
Consumer Name Alpha
17-Hydroxyprogesterone 2 days after dexamethasone, Blood

Basic Attributes

Class
CHAL
Type
Laboratory
First Released
Version 2.29
Last Updated
Version 2.70
Order vs. Observation
Observation

Member of these Groups

LG50724-0 17-Hydroxyprogesterone^2D post dose dexamethasone|Pt|Ser/Plas

Language Variants Get Info

zh-CNChinese (China)
17-羟孕酮^在给予剂量地塞米松之后2天:质量浓度:时间点:血清/血浆:定量型:
nl-NLDutch (Netherlands)
17-hydroxyprogesteron^2 dagen na dosis dexamethason:massa/volume:moment:serum of plasma:kwantitatief:
fr-BEFrench (Belgium)
17-hydroxyprogestérone^2 j post dose dexaméthasone:Concentration de masse:Temps ponctuel:Sérum/Plasma:Quantitatif:
fr-CAFrench (Canada)
17-hydroxyprogestérone^2 j post dose dexaméthasone:Concentration de masse:Temps ponctuel:Sérum/Plasma:Quantitatif:
fr-FRFrench (France)
17-hydroxyprogestérone TJ02 après dexaméthasone:Masse/Volume:Ponctuel:Sérum/Plasma:Numérique:
it-ITItalian (Italy)
17-Idrossiprogesterone^2 gg post dose desametazone:MCnc:Pt:Siero/Plasma:Qn:
pt-BRPortuguese (Brazil)
17-Hidroxiprogesterona^2 dias após dose de dexametasona:#N/A:Pt:Sor/Plas:Qn:
ru-RURussian (Russian Federation)
17-гидроксипрогестерон^2 дня после дозы дексаметазона:МассКонц:ТчкВрм:Сыв/Плаз:Колич:
es-MXSpanish (Mexico)
17-hidroxiprogesterona^2D después de la dosis dexametasona:Concentración de masa:Punto temporal:Suero o Plasma:Cuantitativo:
es-ESSpanish (Spain)
17-hidroxiprogesterona^2D pos dosis de dexametasona:Concentración de masa:Punto temporal:Suero o Plasma:Qn:
tr-TRTurkish (Turkey)
17-Hidroksiprogesteron^2G snr dekzametazon dozu:KütlKons:Zmlı:Ser/Plaz:Kant:

Example Units

Unit Source
ng/mL Example UCUM Units

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=57549-8